Moving from research generation to knowledge translation in end-of-life care in long term care
The recognition and importance of the need for palliative or end-of-life care in long term care has, over the last two decades, led to increased research, education and practice development initiatives in most developed countries. The breadth and depth of some of these initiatives has been catalogued by the European Association of Palliative Care Taskforce on Palliative Care in Long Term Care Settings for Older People. 1, 2 In total over 60 initiatives across 13 European countries were identified. These initiatives were mapped by level of change -that is at the national, regional, organisational, team or individual level, with many targeting more than one level. Unfortunately not possible as part of this mapping activity, was an evaluation to examine if any of these initiatives successfully translated into sustained knowledge or practice change.
What is vital for improving end-of-life care for residents and families in long term care is for clinicians, researchers and policy makers to engage, not only in the generation of knowledge by engaging in research and knowledge dissemination from the publication of results in academic journals, but also the transfer of research-based knowledge into a form that can be used. This process is often referred to as knowledge translation (KT). 3 KT focuses on methods or processes to increase clinician's practice knowledge to improve outcomes and reduce the evidence-practice gap. The nexus between knowledge generation and KT is the synthesis of what is known on a topic (the best evidence available) and what will work in a local context.
There are a number of end-of-life care examples internationally that could be considered examples of KT. These include the Liverpool Care Pathway (UK, Europe, New Zealand, Australia), the Gold Standards Framework (GSF) (UK, USA, Canada, Belgium, Holland, Australia), Honoring Choices Wisconsin (USA), Respecting Patient Choices (Australia) and Physician Orders for Life-Sustaining Treatment (POLST) (USA). Ideally these programmes should be developed based on evidence from randomised controlled trials, or where possible, systematic review and meta-analysis of randomised controlled trials. However, in reality, this level of evidence is either not available, detailed enough or if available not used by policy makers and clinicians. 4 (Strauss et al., 2009 ). In the case of each of these programmes none of them had the evidence from randomised controlled trials or systematic review before being been adopted for use in their respective countries. As most of these programmes have now been widely used for over a decade the evidence base for many has increased, although in the case of the GSF this remains largely descriptive, with uncontrolled and non-randomised studies. 5 The recent controversy over the limited evidence base and failure of implementation of the Liverpool Care Pathway (LCP) is discussed elsewhere. 6 In this issue, the first cluster randomised controlled trial of the Gold Standards Framework in Care Homes (GSFCH) is reported by Kinley et al. The GSFCH is based on the GSF for Primary Care, which was recommended for use by the National Health Service End of Life Care Programme. The GSFCH provides tools, tasks and resources combined with training and central support from the GSF team and local support from a GSFCH facilitator. Desired outcomes are improvements in advance care planning, communication and team working, reductions in hospital transfers and high quality clinical care. In the study by Kinley et al., the GSFCH was implemented in 24 care homes. In addition to the standard GSFCH programme, 12 homes were randomised to receive high facilitation plus action learning (HFAL) and 12 GSFCH with high facilitation (HF). HF is described in detail in the study, and in summary includes appointment and training of local coordinators, visits by the facilitator 2 to 3 times per month, assistance with implementation of the LCP or Integrated Care Pathway (ICP) and role modelling for complex care. Action learning focused on leadership in implementing the GSF and included monthly meetings over 9 months. Both these additions to the standard facilitation provided by the GSFCH programme were based on the author's previous experience in care homes. Acting as a control group, a further 14 nursing homes received standard GSF facilitation. The GSFCH programme is conducted in three phases over approximately 2 years, involving 550146P MJ0010.1177/0269216314550146Palliative MedicineParker
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Results from all three groups demonstrated the effectiveness of the GSFCH with improvements over the 3-year study period in place of death (at the home), cardiopulmonary resuscitation decision in place signed by a General Practitioner (GP) and the completion of an advance care plan. Interestingly, despite the extra support provided in the HF and HFAL, none of these outcomes were statistically significant across the groups. The only significant outcome was the use of an ICP or LCP in the HFAL homes. The most interesting result is the rate of GSFCH accreditation achieved by all three groups, with 83% of the HFAL homes achieving GSFCH accreditation, but only 27% in the HF arm and 7% in the observational arm.
As the first cluster randomised controlled trial for the GSFCH, these results add to the body of evidence for the programme, but raise a number of issues. The main aim of the study was to provide evidence that GSFCH implementation requires a greater level of facilitation to achieve improved outcomes for dying residents than is currently provided. In this endeavour, the authors have failed to show significant differences for place of death, existence of advance care plan or resuscitation decision between any of the groups. While the use of an ICP or LCP was significantly greater in the HFAL group, this did not impact on place of death. Before adoption of HFAL as standard facilitation for the GSFCH, it would be necessary to identify the impact of a greater number of residents dying on an ICP or LCP on quality of death. However, at present this study does not support that the GSFCH programme requires a higher level of facilitation to achieve the main resident outcomes. A secondary issue is the usefulness of the GSFCH accreditation programme. Nationally the GSFCH accreditation rate is 13%. 5 That only the HFAL homes could achieve an acceptable level of GSFCH accreditation (83%) highlights the administrative burden to achieve accreditation, and indicates the process and purpose of accreditation requires review.
It is important for improving the end-of-life care for older people in long term care that knowledge continues to be generated, where possible using robust research designs with interventions that can be directly transferable from research to practice. However, is it practical to wait until this highest level of evidence is produced before care is delivered and are different levels of evidence appropriate for KT? Evans 7 argues that the current hierarchy of evidence privileges the effectiveness of the intervention. He argues that evidence for the appropriateness and feasibility of interventions should also be considered and that a revised hierarchy of evidence for this is required. He does not discount the importance of randomised controlled trials, but argues that interpretive and observational research will provide insight as to whether it is appropriate to use the intervention proven to be effective or how feasible within a local context is the intervention. The article by Kinley et al. demonstrates this tension. The GSFCH programme within their cluster randomised control trial demonstrated effectiveness by reduction of hospital deaths and increase in advance care planning for residents. This design also provided good evidence on the feasibility of the intervention from the point of the implementation of the outcome measures, but was less effective in unpacking issues related to implementation or the organisational culture on implementation -the issue of achieving accreditation. A similar argument is provided by Greenhaugh et al., 8 who are questioning whether the evidence-based medicine movement is in crisis. Like Evans, 7 they argue that useable evidence is required in combination with context and professional expertise. This juggling between the level of evidence and context is the challenge for those who generate as well as use evidence in palliative care.
